Related references
Note: Only part of the references are listed.Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
Giulia Pavani et al.
NATURE COMMUNICATIONS (2020)
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
Hongyi Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
Giulia Schiroli et al.
CELL STEM CELL (2019)
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
Christopher E. Nelson et al.
NATURE MEDICINE (2019)
Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates
Zulema Romero et al.
MOLECULAR THERAPY (2019)
Gene correction for SCID-X1 in long-term hematopoietic stem cells
Mara Pavel-Dinu et al.
NATURE COMMUNICATIONS (2019)
NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia
Francisco Jose Roman-Rodriguez et al.
CELL STEM CELL (2019)
Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia
Paula Rio et al.
NATURE MEDICINE (2019)
High levels of AAV vector integration into CRISPR-induced DNA breaks
Killian S. Hanlon et al.
NATURE COMMUNICATIONS (2019)
Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
Natalia Gomez-Ospina et al.
NATURE COMMUNICATIONS (2019)
In vivo genome editing via the HITI method as a tool for gene therapy
Keiichiro Suzuki et al.
JOURNAL OF HUMAN GENETICS (2018)
Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells
M. Kyle Cromer et al.
MOLECULAR THERAPY (2018)
CRISPR/Cas9 genome editing in human hematopoietic stem cells
Rasmus O. Bak et al.
NATURE PROTOCOLS (2018)
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome
Caroline Y. Kuo et al.
CELL REPORTS (2018)
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1
Giulia Schiroli et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients
Paula Rio et al.
BLOOD (2017)
Homology-mediated end joining-based targeted integration using CRISPR/Cas9
Xuan Yao et al.
CELL RESEARCH (2017)
Cell cycle regulation of hematopoietic stem or progenitor cells
Sha Hao et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Keiichiro Suzuki et al.
NATURE (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
Targeted gene addition in human CD34+ hematopoietic cells for correction of X-linked chronic granulomatous disease
Suk See De Ravin et al.
NATURE BIOTECHNOLOGY (2016)
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency
Suk See De Ravin et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Human hematopoietic stem cells from mobilized peripheral blood can be purified based on CD49f integrin expression
Heather D. Huntsman et al.
BLOOD (2015)
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
Jianbin Wang et al.
NATURE BIOTECHNOLOGY (2015)
Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases
Sangsu Bae et al.
BIOINFORMATICS (2014)
Targeted genome editing in human repopulating haematopoietic stem cells
Pietro Genovese et al.
NATURE (2014)
Gene Therapy for Wiskott-Aldrich Syndrome-Long-Term Efficacy and Genotoxicity
Christian Joerg Braun et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer
Marco Ranzani et al.
NATURE METHODS (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Alessandra Biffi et al.
SCIENCE (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Thomas Gaj et al.
TRENDS IN BIOTECHNOLOGY (2013)
Hematologically important mutations: Leukocyte adhesion deficiency (first update)
Edith van de Vijver et al.
BLOOD CELLS MOLECULES AND DISEASES (2012)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
FLASH: fast length adjustment of short reads to improve genome assemblies
Tanja Magoc et al.
BIOINFORMATICS (2011)
Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update
B. Mohty et al.
BLOOD CANCER JOURNAL (2011)
Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils
Elizabeth M. Kang et al.
BLOOD (2010)
Hematopoietic Stem Cell Quiescence Promotes Error-Prone DNA Repair and Mutagenesis
Mary Mohrin et al.
CELL STEM CELL (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
A Simplified Baculovirus-AAV Expression Vector System Coupled With One-step Affinity Purification Yields High-titer rAAV Stocks From Insect Cells
Richard H. Smith et al.
MOLECULAR THERAPY (2009)
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.
Alessandro Aiuti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Comparison of nonhomologous end joining and homologous recombination in human cells
Zhiyong Mao et al.
DNA REPAIR (2008)
Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein
Miguel G. Toscano et al.
HUMAN GENE THERAPY (2008)
Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors
Thomas R. Bauer et al.
NATURE MEDICINE (2008)
Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector
HB Gaspar et al.
LANCET (2004)
Adeno-associated virus vectors integrate at chromosome breakage sites
DG Miller et al.
NATURE GENETICS (2004)
The degree of phenotypic correction of murine β-thalassemia intermedia following lentiviral-mediated transfer of a human γ-globin gene is influenced by chromosomal position effects and vector copy number
DA Persons et al.
BLOOD (2003)
Gene therapy of X-linked severe combined immunodeficiency
Marina Cavazzana-Calvo et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Insect cells as a factory to produce adeno-associated virus type 2 vectors
M Urabe et al.
HUMAN GENE THERAPY (2002)
Gene therapy of X-linked severe combined immunodeficiency
S Hacein-Bey-Abina et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2002)
Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells
RD Johnson et al.
EMBO JOURNAL (2000)
Share Paper
